2024-03-28T15:59:42Z
http://repoint.unil.ch/oaiprovider/
oai:serval.unil.ch:BIB_C0EF3DC2B414
2024-03-23T02:55:56Z
serval:BIB_C0EF3DC2B414
The efficacy and safety of a third anti-TNF monoclonal antibody in Crohn's disease after failure of two other anti-TNF antibodies.
10.1111/j.1365-2036.2009.04130.x
000272379900011
19709098
Allez
M.
author
Vermeire
S.
author
Mozziconacci
N.
author
Michetti
P.
author
Laharie
D.
author
Louis
E.
author
Bigard
M.A.
author
Hébuterne
X.
author
Treton
X.
author
Kohn
A.
author
Marteau
P.
author
Cortot
A.
author
Nichita
C.
author
van Assche
G.
author
Rutgeerts
P.
author
Lémann
M.
author
Colombel
J.F.
author
article
2010
Alimentary Pharmacology & Therapeutics
1365-2036[electronic]
journal
31
1
92-101
Antitumor Necrosis Factor
Inflammatory-Bowel-Disease
Certolizumab Pegol CDP870
Factor-Alpha
Maintenance Therapy
Open-Label
Clinical-Response
Randomized-Trial
Sture Registry
Lost Response
eng
60_published
true